Pharmiweb.com RSS Feeds 
PharmiWeb Candidate Blog
Features
28 Jul 09
Ahead of the NHS Confederation Conference last month, David Nicholson, Chief Executive of NHS pulled no punches with his assessment of NHS finances.
Miriam George
27 Jul 09
ABPI have developed an on-line exam bookings website to facilitate the process of booking the ABPI Medical Representatives Exam.
ABPI
22 Jul 09
Generational stereotypes are never easy to swallow, but when it comes to doctors and an investment in social media, the new generations of medical professionals are increasingly going online for both professional collaboration and patient support.
Max Golby
15 Jul 09
With increased investment in R&D largely failing to fill drug development pipelines, the pharma industry is looking to get more bang for its R&D buck by generating some return out of failed drug candidates and extra return out of others. Drug re-positioning has become a key strategy for pharmaceutical groups, and according to Datamonitor, this approach is set to become more frequently employed.
Priyanka Adhikari
01 Jul 09
Spanning one third of the globe's circumference and home to more than half of the world's population, the Asia Pacific region is incredibly diverse. This year's World Vaccine Congress Asia highlighted the enormous variation in the vaccine landscape in the region, owing to a myriad of political, cultural, economic and geographic differences.
Priyanka Adhikari
.jpg)
18 Jun 09
Field reporter Rhonda Siddall reports from EULAR
Rhonda Siddall - Pharmiweb Field Reporter
16 Jun 09
Quick Look article from Max Golby about Alternative Therapies
Max Golby
15 Jun 09
Unless it paints the right picture you’re letting the side down!
In a depressed job market, an employer is likely to receive 50+ CVs per job advertised from 5 or more Preferred Agencies and many more from agencies who ‘piggy back’ in. So now, more than ever, your CV needs to stand out and be tailored to the role and client and submitted by an agency with valid access.
Avril Horn PhD
12 Jun 09
Datamonitor attended the American Society of Clinical Oncology's 45th Annual Meeting in Orlando, Florida, to assess the key highlights of the conference. A number of promising presentations evaluated the potential of currently marketed agents to successfully combine with conventional chemotherapy in indications with persistent high unmet needs.
Datamonitor
03 Jun 09
Quick Look article written by Max Golby, focusing on topic of swine flu.
Max Golby
01 Jun 09
The Department of Health is determined to improve commissioning, and it will do whatever it takes to make it happen. That is the message that senior departmental officials sent to practice based commissioners last week at a National Association of Primary Care conference in London.
Miriam George
01 Jun 09
The time has arrived for primary care trusts to shed their provider functions, and it is causing considerable angst in the community services sector. It was inevitable that sooner or later, the split would have to happen, but now the race is on to decide what organisation model they want to adopt: foundation trust or social enterprise?
Miriam George
20 May 09
Senior Department of Health executives, speaking at a recent NHS Alliance Conference, suggested that the NHS has two years left before it starts to the credit crunch’s bite – maybe less if there is an election in a years’ time. But this should not be cause complacency in the health sector. The message is, invest wisely now so that you are well prepared for the fallow times ahead.
PDC Healthcare
18 May 09
The growing incidence of diseases and conditions related to aging is creating pockets of opportunity for pain management. These opportunities include the expanding use of prescription NSAIDs as second-line therapies for chronic pain and an increase in off-label prescribing. As populations and indications evolve, so too is the pain management sector.
Applied Data Research
.jpg)
14 May 09
In this edition of StrategicEdge, CBR Pharma Insights discusses the current trends and opportunities that exist in marketing to consumers as the age of TiVo, DVRs, and cost constraints point the industry towards creative uses of the internet and other e-technologies.
CBR Pharma Insights
13 May 09
Integrated Care Organisations (ICOs) are the new kids on the block, and tipped as the natural successor to practice based commissioning.
Miriam George
.gif)
11 May 09
The recent outbreak of influenza A (H1N1) infection, previously referred to as swine flu, has thrown the spotlight on governments around the world and their ability to manage a pandemic. In the UAE, customers are currently finding it difficult to source antivirals but, with Dubai seen as a hub for international travel, the government has stockpiles ready for distribution should an outbreak occur.
Datamonitor
08 May 09
There has been no shortage of conversation lately about current problems facing the Pharmaceutical industry...
Fred Beadon
.jpg)
30 Apr 09
The latest outbreak of influenza virus H1N1 “swine flu” is now widely tipped to cause a global pandemic of unknown severity. Previously, the influenza vaccine community discussed the theoretical limitations of current technologies and capacity. Now they are faced with the reality of these limitations. VacZine Analytics believes H1N1 must change the science of influenza vaccines.
VacZine Analytics Group
30 Apr 09
Where the pharmaceutical industry is often said to be immune to economic depression, the current economic crisis cannot be considered a direct historical equal to the recessions of the past.
Max Golby
28 Apr 09
Public opinion has for long been regarded as essential to the success of a thriving business. In fact, whilst the benefits of popular perception can often appear somewhat intangible on the balance sheet, what is essentially the respect of the customer is the bastion of almost every profession
Max Golby
20 Apr 09
Any positive effect on the pharmaceutical industry derived from the G20 summit and European Union summit will be indirect and much of the direct healthcare spending increase will cover the cost of cheaper generics accessed through publically funded programs. Furthermore, emerging markets previously targeted to drive revenue growth face potentially crippling consequences from the downturn.
Pharmiweb editor
06 Apr 09
Medical communications provide professional, valuable marketing solutions to pharmaceutical companies, incorporating; writing, design, multimedia, conferences and events and more.
Claire Phillpot
03 Apr 09
We have all heard the doom and gloom regarding the financial markets/ credit crunch/ recession. It’s pretty hard to escape it. The high earning bankers are jobless and the face of our high street is changing with high profile collapses of organisations including Woolworths, the Officers Club, MFI and Barretts.
Chantal Williams- RSA executive search consultant
03 Apr 09
It is perhaps fitting, if not entirely coincidental, that the month that we chose to focus on the important areas of the central nervous system and pain, also coincides with Multiple Sclerosis Awareness Month.
Max Golby
31 Mar 09
For some patients, namely those suffering from terminal illness, pain relief is an issue that talks to them about the right to end their lives in relative comfort and dignity. In such situations, new kinds of research that attack the complications and side effects of high level pain killers – such as opium based pain relievers – are particularly pertinent.
Max Golby
16 Mar 09
Adventis Health is one of a number of medical communications agencies that offers an integrated service with advertising, PR, Medical Education and digital media all available in house.
Adventis Health
12 Mar 09
Latest research from strategic consultancy VacZine Analytics(R) suggests that the expert community is leaning towards the idea of priming the population now against a possible influenza pandemic. The concept referred to as pre emtive or “early” immunological priming, is faced with obstacles, but possibly not as many as those linked with current pandemic vaccine strategies.
VacZine Analytics Group
11 Mar 09
In January, leading pharmaceutical experts attended the 2009 Forum Institute seminar on biosimilars, and the challenges involved in their successful development and launch. While the main focus of the meeting the biosimilars market in the EU, it was widely agreed that developments in the US, and President Obama's handling of the generic biotech issue, will be the defining issue of 2009 and beyond.
Editor
10 Mar 09
20 minutes preparation can make all the difference!
People don’t interview everyday! Lets face it, its not always easy. The purpose of this short article is to help you prepare fully for your interview.
Phlexglobal Ltd
